Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines

Journal of Chinese Integrative Medicine

Volumn 7, Issue 12, 2009, Pages 1174-1180

  Deng, Ying ^a   Chen, Hong Feng ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRAGALOSIDE IV; ASTRAGALUS EXTRACT; FORMONONETIN; PROTEIN KINASE B; SERINE; THREONINE; ASTRAGALOSIDE A; ISOFLAVONE DERIVATIVE; ONCOPROTEIN; PHYTOESTROGEN; SAPONIN; TRITERPENE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; APOPTOSIS; ASTRAGALUS (PLANT); BREAST TUMOR; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

APOPTOSIS; ASTRAGALUS PLANT; BREAST NEOPLASMS; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOFLAVONES; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PHYTOESTROGENS; SAPONINS; TRITERPENES;

EID: 74949085718     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20091216     Document Type: Article

References (11)

1. Shen ZZ, Shao ZM. Breast tumor[M]. Shanghai: Shanghai Scientific and Technical Publishers, 2005. 1-2. Chinese.
2. Qin HG. Professor Tang Han-Jun's thinking in syndrome differentiation and experience in treating breast cancer[J] Chin Integr Med, 2004, 2(4) : 297-298. Chinese.
3. Lu DM. Qi- and ying-tonifying method for breast cancer patients after mastectomy[J]. Shanghai Zhong Yi Yao Da Xue Xue Bao, 2008, 22(1) : 1-3. Chinese.
4. Liu PX, Zhou RF, Tan M. Effects of Astragalus injection on proliferation and apoptosis of basal-like breast cancer cell line MDA-MB-231[J]. Zhonghua Ru Xian Bing Xue Za Zhi, 2009, 3(2) : 28-31. Chinese with abstract in English.
5. Ye MN, Chen HF. Effects of Astragalus injection on proliferation of basal-like breast cancer cell line MDA-MB-468[J] J Chin Integr Med, 2008, 6(4) : 399-404. Chinese with abstract in English.
6. Gusterson BA, Ross DT, Heath VJ, Stein T. Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer[J]. Breast Cancer Res, 2005, 7(4) : 143-148.
7. Langer□d A, Zhao H, Borgan □, Nesland JM, Bukholm IR, Ikdahl T, K□resen R, B□rresen-Dale AL, Jeffrey SS. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer[J]. Breast Cancer Res, 2007, 9(3) : R30.
8. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J]. Clin Cancer Res, 2004, 10(16) : 5367-5374.
9. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressier L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM. The molecular portraits of breast tumors are conserved across microarray platforms[J]. BMC Genomics, 2006, (7) : 96.
10. van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, Torhorst J, Sauter G, Zuber M, K□chli OR, Mross F, Dieterich H, Seitz R, Ross D, Botstein D, Brown P. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome[J]. Am J Pathol, 2002, 161(6) : 1991-1996.
11. Korsching E, Packeisen J, Agelopoulos K, Eisenacher M, Voss R, Isola J, van Diest PJ, Brandt B, Boecker W, Buerger H. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis[J]. Lab Invest, 2002, 82(11) : 1525-1533.